Apparel - Retail
Compare Stocks
4 / 10Stock Comparison
DXLG vs DDS vs M vs KSS
Revenue, margins, valuation, and 5-year total return — side by side.
Department Stores
Department Stores
Department Stores
DXLG vs DDS vs M vs KSS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Apparel - Retail | Department Stores | Department Stores | Department Stores |
| Market Cap | $35M | $6.60B | $5.34B | $1.61B |
| Revenue (TTM) | $442M | $6.56B | $22.62B | $15.53B |
| Net Income (TTM) | $-8M | $571M | $642M | $271M |
| Gross Margin | 44.4% | 38.3% | 36.5% | 36.1% |
| Operating Margin | -2.3% | 10.5% | 4.6% | 3.3% |
| Forward P/E | — | 16.3x | 8.8x | 10.3x |
| Total Debt | $0.00 | $358M | $5.20B | $2.45B |
| Cash & Equiv. | $24M | $862M | $1.25B | $674M |
DXLG vs DDS vs M vs KSS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Destination XL Grou… (DXLG) | 100 | 149.8 | +49.8% |
| Dillard's, Inc. (DDS) | 100 | 1844.3 | +1744.3% |
| Macy's, Inc. (M) | 100 | 302.4 | +202.4% |
| Kohl's Corporation (KSS) | 100 | 74.7 | -25.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DXLG vs DDS vs M vs KSS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DXLG lags the leaders in this set but could rank higher in a more targeted comparison.
DDS carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 1.15, yield 5.6%
- Rev growth -0.4%, EPS growth -1.0%, 3Y rev CAGR -2.1%
- 8.7% 10Y total return vs M's -24.5%
- Lower volatility, beta 1.15, Low D/E 15.2%, current ratio 2.65x
M is the #2 pick in this set and the best alternative if value is your priority.
- Lower P/E (8.8x vs 16.3x)
KSS is the clearest fit if your priority is momentum.
- +127.8% vs DXLG's -35.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.4% revenue growth vs DXLG's -6.9% | |
| Value | Lower P/E (8.8x vs 16.3x) | |
| Quality / Margins | 8.7% margin vs DXLG's -1.7% | |
| Stability / Safety | Beta 1.15 vs KSS's 2.32, lower leverage | |
| Dividends | 5.6% yield, 12-year raise streak, vs M's 3.7%, (1 stock pays no dividend) | |
| Momentum (1Y) | +127.8% vs DXLG's -35.6% | |
| Efficiency (ROA) | 16.3% ROA vs DXLG's -1.9%, ROIC 29.7% vs -6.8% |
DXLG vs DDS vs M vs KSS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DXLG vs DDS vs M vs KSS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DDS leads in 4 of 6 categories
DXLG leads 1 • M leads 0 • KSS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
DDS leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
M is the larger business by revenue, generating $22.6B annually — 51.2x DXLG's $442M. DDS is the more profitable business, keeping 8.7% of every revenue dollar as net income compared to DXLG's -1.7%. On growth, M holds the edge at -1.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $442M | $6.6B | $22.6B | $15.5B |
| EBITDAEarnings before interest/tax | $5M | $868M | $1.9B | $1.2B |
| Net IncomeAfter-tax profit | -$8M | $571M | $642M | $271M |
| Free Cash FlowCash after capex | -$11M | $620M | $1.1B | $1.2B |
| Gross MarginGross profit ÷ Revenue | +44.4% | +38.3% | +36.5% | +36.1% |
| Operating MarginEBIT ÷ Revenue | -2.3% | +10.5% | +4.6% | +3.3% |
| Net MarginNet income ÷ Revenue | -1.7% | +8.7% | +2.8% | +1.7% |
| FCF MarginFCF ÷ Revenue | -2.6% | +9.5% | +4.7% | +7.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.2% | -3.0% | -1.1% | -4.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -137.7% | -3.1% | +51.2% | +153.5% |
Valuation Metrics
DXLG leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 6.1x trailing earnings, KSS trades at a 60% valuation discount to DDS's 15.2x P/E. On an enterprise value basis, KSS's 2.8x EV/EBITDA is more attractive than DDS's 7.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $35M | $6.6B | $5.3B | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $11M | $6.1B | $9.3B | $3.4B |
| Trailing P/EPrice ÷ TTM EPS | -0.97x | 15.19x | 8.29x | 6.06x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.32x | 8.79x | 10.26x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 7.02x | 4.83x | 2.80x |
| Price / SalesMarket cap ÷ Revenue | 0.08x | 1.01x | 0.24x | 0.10x |
| Price / BookPrice ÷ Book value/share | 0.32x | 3.67x | 1.09x | 0.41x |
| Price / FCFMarket cap ÷ FCF | 18.82x | 10.58x | 5.05x | 1.46x |
Profitability & Efficiency
DDS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
DDS delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-5 for DXLG. DDS carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to M's 1.07x. On the Piotroski fundamental quality scale (0–9), M scores 7/9 vs DXLG's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.5% | +24.3% | +14.2% | +6.9% |
| ROA (TTM)Return on assets | -1.9% | +16.3% | +4.0% | +2.0% |
| ROICReturn on invested capital | -6.8% | +29.7% | +8.7% | +4.6% |
| ROCEReturn on capital employed | -6.4% | +26.0% | +8.7% | +4.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 | 7 | 7 |
| Debt / EquityFinancial leverage | — | 0.15x | 1.07x | 0.61x |
| Net DebtTotal debt minus cash | -$24M | -$504M | $4.0B | $1.8B |
| Cash & Equiv.Liquid assets | $24M | $862M | $1.2B | $674M |
| Total DebtShort + long-term debt | $0 | $358M | $5.2B | $2.5B |
| Interest CoverageEBIT ÷ Interest expense | — | — | 10.62x | 2.17x |
Total Returns (Dividends Reinvested)
DDS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DDS five years ago would be worth $62,422 today (with dividends reinvested), compared to $3,516 for KSS. Over the past 12 months, KSS leads with a +127.8% total return vs DXLG's -35.6%. The 3-year compound annual growth rate (CAGR) favors DDS at 29.5% vs DXLG's -47.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -28.9% | -13.1% | -14.6% | -32.1% |
| 1-Year ReturnPast 12 months | -35.6% | +65.5% | +72.1% | +127.8% |
| 3-Year ReturnCumulative with dividends | -85.6% | +117.3% | +41.5% | -9.7% |
| 5-Year ReturnCumulative with dividends | -55.2% | +524.2% | +26.9% | -64.8% |
| 10-Year ReturnCumulative with dividends | -88.1% | +872.1% | -24.5% | -25.3% |
| CAGR (3Y)Annualised 3-year return | -47.6% | +29.5% | +12.3% | -3.3% |
Risk & Volatility
Evenly matched — DDS and M each lead in 1 of 2 comparable metrics.
Risk & Volatility
DDS is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than KSS's 2.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. M currently trades 78.8% from its 52-week high vs DXLG's 37.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.30x | 1.15x | 1.42x | 2.32x |
| 52-Week HighHighest price in past year | $1.69 | $741.98 | $24.41 | $25.22 |
| 52-Week LowLowest price in past year | $0.43 | $348.08 | $10.54 | $6.47 |
| % of 52W HighCurrent price vs 52-week peak | +37.9% | +74.6% | +78.8% | +56.9% |
| RSI (14)Momentum oscillator 0–100 | 58.2 | 44.9 | 56.6 | 50.7 |
| Avg Volume (50D)Average daily shares traded | 144K | 99K | 6.6M | 4.6M |
Analyst Outlook
DDS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DDS as "Hold", M as "Hold", KSS as "Hold". Consensus price targets imply 25.4% upside for KSS (target: $18) vs -0.2% for M (target: $19). For income investors, DDS offers the higher dividend yield at 5.62% vs KSS's 3.39%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $555.00 | $19.20 | $18.00 |
| # AnalystsCovering analysts | — | 13 | 40 | 39 |
| Dividend YieldAnnual dividend ÷ price | — | +5.6% | +3.7% | +3.4% |
| Dividend StreakConsecutive years of raises | 0 | 12 | 4 | 0 |
| Dividend / ShareAnnual DPS | — | $31.08 | $0.71 | $0.49 |
| Buyback YieldShare repurchases ÷ mkt cap | +39.2% | 0.0% | +4.7% | 0.0% |
DDS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). DXLG leads in 1 (Valuation Metrics). 1 tied.
DXLG vs DDS vs M vs KSS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DXLG or DDS or M or KSS a better buy right now?
For growth investors, Dillard's, Inc.
(DDS) is the stronger pick with -0. 4% revenue growth year-over-year, versus -6. 9% for Destination XL Group, Inc. (DXLG). Kohl's Corporation (KSS) offers the better valuation at 6. 1x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate Dillard's, Inc. (DDS) a "Hold" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DXLG or DDS or M or KSS?
On trailing P/E, Kohl's Corporation (KSS) is the cheapest at 6.
1x versus Dillard's, Inc. at 15. 2x. On forward P/E, Macy's, Inc. is actually cheaper at 8. 8x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — DXLG or DDS or M or KSS?
Over the past 5 years, Dillard's, Inc.
(DDS) delivered a total return of +524. 2%, compared to -64. 8% for Kohl's Corporation (KSS). Over 10 years, the gap is even starker: DDS returned +872. 1% versus DXLG's -88. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DXLG or DDS or M or KSS?
By beta (market sensitivity over 5 years), Dillard's, Inc.
(DDS) is the lower-risk stock at 1. 15β versus Kohl's Corporation's 2. 32β — meaning KSS is approximately 102% more volatile than DDS relative to the S&P 500. On balance sheet safety, Dillard's, Inc. (DDS) carries a lower debt/equity ratio of 15% versus 107% for Macy's, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DXLG or DDS or M or KSS?
By revenue growth (latest reported year), Dillard's, Inc.
(DDS) is pulling ahead at -0. 4% versus -6. 9% for Destination XL Group, Inc. (DXLG). On earnings-per-share growth, the picture is similar: Kohl's Corporation grew EPS 144. 3% year-over-year, compared to -1420. 0% for Destination XL Group, Inc.. Over a 3-year CAGR, DDS leads at -2. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DXLG or DDS or M or KSS?
Dillard's, Inc.
(DDS) is the more profitable company, earning 8. 7% net margin versus -8. 3% for Destination XL Group, Inc. — meaning it keeps 8. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DDS leads at 10. 5% versus -4. 2% for DXLG. At the gross margin level — before operating expenses — DXLG leads at 43. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DXLG or DDS or M or KSS more undervalued right now?
On forward earnings alone, Macy's, Inc.
(M) trades at 8. 8x forward P/E versus 16. 3x for Dillard's, Inc. — 7. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KSS: 25. 4% to $18. 00.
08Which pays a better dividend — DXLG or DDS or M or KSS?
In this comparison, DDS (5.
6% yield), M (3. 7% yield), KSS (3. 4% yield) pay a dividend. DXLG does not pay a meaningful dividend and should not be held primarily for income.
09Is DXLG or DDS or M or KSS better for a retirement portfolio?
For long-horizon retirement investors, Dillard's, Inc.
(DDS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 5. 6% yield, +872. 1% 10Y return). Destination XL Group, Inc. (DXLG) carries a higher beta of 2. 30 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DDS: +872. 1%, DXLG: -88. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DXLG and DDS and M and KSS?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DXLG is a small-cap quality compounder stock; DDS is a small-cap deep-value stock; M is a small-cap deep-value stock; KSS is a small-cap deep-value stock. DDS, M, KSS pay a dividend while DXLG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.